Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Onconetix, Inc. (ONCO)

  • Technical Exchange News
  • Sept. 20, 2024, 19:20 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Sept. 20, 2024, 02:04 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cognition Therapeutics Inc. (CGTX)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Sept. 19, 2024, 18:41 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cognition Therapeutics Inc. (CGTX)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

G1 Therapeutics Inc (GTHX)

  • Technical Exchange News
  • Sept. 19, 2024, 07:10 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: G1 Therapeutics, Inc. - Common Stock. New value: G1 Therapeutics, Inc. - Common Stock.

Comment Full text
  • Previous
  • 467
  • 468
  • 469
  • 470
  • 471
  • Next

Search

News categories

  • Technical Exchange News(11623)
  • Event(3831)
  • SEC News(223292)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140080)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin